new study
Media Release
Read more
News Brief: TrialNet Explores Plasmid Therapy for Type 1 Diabetes
Phase 1 study now recruiting adults diagnosed in past 4 years
Phase 1 study now recruiting adults diagnosed in past 4 years
TrialNet is excited to announce the launch of our first Phase 1 clinical study to test a new plasmid therapy. The study will enroll 48 adults (age 18-45) diagnosed with type 1 diabetes (T1D) in the past 4 years.